KX2-361
/ Athenex, Guangzhou Xiangxue Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 21, 2024
Tirbanibulin (KX2-391) analog KX2-361 inhibits botulinum neurotoxin serotype A mediated SNAP-25 cleavage in pre- and post-intoxication models in cells.
(PubMed, Drug Dev Res)
- "Furthermore, our molecular docking analyses suggested that KX2-361 can directly bind to BoNT/A LC. Medicinal chemistry approaches to develop structural analogs of KX2-361 to increase its efficacy against BoNT/A may provide a critical lead compound with BBB penetration capacity for drug development efforts against BoNT/A intoxication."
Journal
January 18, 2019
Strain improvement and statistical optimization as a combined strategy for improving fructosyltransferase production by Aureobasidium pullulans NAC8.
(PubMed, J Genet Eng Biotechnol)
- "...KX023301) was carried out using chemical mutagens such as ethidium bromide and ethyl methane sulfonate...A relatively low FTase-producing strain of Aureobasidium pullulans NAC8 was enhanced for optimum production using a two-pronged approach involving mutagenesis and statistical optimization. The improved mutant strain also had remarkable biotechnological properties that make it a suitable alternative than the wild-type."
Journal
January 13, 2019
"In #KeineWochenShow 106 auf #Youtube ist @ShaiHoffmann zu Gast. Es geht um gesellschaftliches #Engagement, die #Wahlen den #Demokratiebus, #Israel, den #ESC2019, #StarSearch und #Greensession. https://t.co/LTYcKx02tM"
(@RT_Zapper)
1 to 3
Of
3
Go to page
1